发明名称 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
摘要 A method of generating a chronic myelogenic leukemia (CML) acquired chemoresistant culture model is provided. Such a method may comprise providing a naïve blast crisis CML cell line; administering/contacting the cell line with a mutation-inducing dose of imatinib; maintaining a culture of the treated cell line for a period of time until the treated cell line relapses and repopulates the culture; and determining the repopulated cell culture is a CML acquired chemoresistant cell line by detecting a BCR-ABL mutation, wherein the acquired chemoresistance is achieved by a BCR-ABL mutation.
申请公布号 US9176114(B2) 申请公布日期 2015.11.03
申请号 US201313922141 申请日期 2013.06.19
申请人 CITY OF HOPE 发明人 Chen WenYong;Bhatia Ravi;Su Leila;Yuan Yate-Ching
分类号 A61K35/14;C12N5/0786;C12N5/09;C12P19/34;G01N33/50 主分类号 A61K35/14
代理机构 Perkins Coie LLP 代理人 Perkins Coie LLP ;Dueppen Laura J.
主权项 1. A culture model of chronic myelogenic leukemia (CML) acquired chemoresistant cells, the model generated by: contacting a blast crisis CML cell line, which has previously not been exposed to imatinab before, with a dose of imatinib sufficient to induce a BCR-ABL mutation, wherein the blast crisis CML cell line is a KCL-22 cell line; maintaining a culture of the imatinib-treated cell line for about two to three weeks until the cell line relapses and repopulates the culture; and determining that the repopulated cell culture is a CML acquired chemoresistant cell line by detecting a BCR-ABL mutation.
地址 Duarte CA US